Author Correction: Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Jianbo Dong, Betty Huang, Bo Wang, Allison Titong, Sachith Gallolu Kankanamalage, Zhejun Jia, Meredith Wright, Pannaga Parthasarathy, Yue Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c7504889cf7242c099524d8e63f1fa4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
por: Dapeng Sun, et al.
Publicado: (2021) -
A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Xun Chen, et al.
Publicado: (2021) -
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
por: Leo Hanke, et al.
Publicado: (2020) -
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
por: Guillermo Valenzuela Nieto, et al.
Publicado: (2021) -
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
por: Tânia F. Custódio, et al.
Publicado: (2020)